A protocol developing, disseminating and implementing a core outcome set for infertility.
James M N DuffyS BhattacharyaC CurtisJ L H EversR G FarquharsonS FranikY KhalafR S LegroS LensenB W MolC NiederbergerE H Y NgS ReppingA StrandellH L TorranceA VailM van WelyLan Ngoc VuongAlex Y WangRui WangJack WilkinsonM A YoussefC M Farquharnull nullPublished in: Human reproduction open (2018)
This project is funded by the Royal Society of New Zealand Catalyst Fund (3712235). BWM reports consultancy fees from Guerbet, Merck, and ObsEva. R.S.L. reports consultancy fees from Abbvie, Bayer, Fractyl and Ogeda and research sponsorship from Ferring. S.B. is the Editor-in-Chief of Human Reproduction Open. The remaining authors declare no competing interests.
Keyphrases
- quality improvement
- endothelial cells
- adverse drug
- randomized controlled trial
- minimally invasive
- health insurance
- induced pluripotent stem cells
- pluripotent stem cells
- ionic liquid
- highly efficient
- reduced graphene oxide
- polycystic ovary syndrome
- metabolic syndrome
- skeletal muscle
- adipose tissue
- electronic health record
- insulin resistance
- gold nanoparticles